Abel Hall »

Akebia Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 11k 2.73
2025-06-30 $39k 11k 3.64

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Small Cap V (DISV)
Apple (AAPL)
Dimensional Etf Trust Intl High Profit (DIHP)
Amazon (AMZN)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Global Core Plus (DFGP)
Exxon Mobil Corporation (XOM)

View all positions for Abel Hall

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics